Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator

• Published in: European journal of drug metabolism and pharmacokinetics Vol. 25; no. 2; pp. 137 - 143
• Main Authors: MUNEER, E, BELL, J, DOCTOR, V. M
• Format: Journal Article
• Language: English
• Published: Genève Médecine et hygiène 01.04.2000
• Subjects: Biological and medical sciences; Chromatography, Affinity; Cyanogen Bromide - pharmacology; Fibrinogen - pharmacology; General pharmacology; Humans; Medical sciences; Pharmacognosy. Homeopathy. Health food; Pharmacology. Drug treatments; Plasminogen - metabolism; Polysaccharides - pharmacology; Tissue Plasminogen Activator - metabolism; Algae; Anticoagulant; In vitro; Marine environment; Heterokontophyta; Fucus vesiculosus; Activator; Fibrinogen; Plant origin; Plasminogen; Mechanism of action; Thallophyta; Phaeophyceae
• ISSN: 0378-7966; 2107-0180
• DOI: 10.1007/BF03190080

The interactions of fucoidan with human glutamic type plasminogen (Glu-Plg), porcine pancreatic elastase digested plasminogen fractions and two chain tissue plasminogen activator t-PA) were investigated using fucoidan-Sepharose affinity chromatography. The results showed a high degree of affinity between fucoidan-Sepharose and Glu-Plg or PlgK(1-3) but not with PlgK4 or mini-Plg. Fucoidan-Sepharose also showed a high affinity for t-PA, which was largely reversed by 0.002 M 6-aminohexanoic acid (6-AH). The addition of fucoidan and CNBr-fibrinogen digest (CNBr-Fbg) gave the highest enhancement of the in vitro activation of Glu-Plg by t-PA in the presence of 0.002 M 6-AH. The results of affinity chromatography and enhancement studies suggested a template mechanism, since increasing the concentrations of any one of the two cofactors reversed the enhancement. Enzyme kinetic studies, using double reciprocal plots, showed that the addition of fucoidan-6-AH increased Kcat by 7-fold without affecting Km and addition of CNBr-Fbg lowered Km by 5-fold without significantly affecting Kcat while addition of the two cofactors lowered Km by 16-fold without significantly affecting Kcat. The enhancement by fucoidan-6-AH or by CNBr-Fbg of the in vitro activation of Glu-Plg by t-PA was reversed by plasminogen activator inhibitor 1 (PAI-1). Fucoidan-Sepharose affinity chromatography revealed that the binding of PAI-1 with fucoidan may be responsible for the reversal of the enhancement by fucoidan-6-AH.